Geny: a genotyping tool for allelic decomposition of killer cell immunoglobulin-like receptor genes

Front Immunol. 2024 Dec 23:15:1494995. doi: 10.3389/fimmu.2024.1494995. eCollection 2024.

Abstract

Introduction: Accurate genotyping of Killer cell Immunoglobulin-like Receptor (KIR) genes plays a pivotal role in enhancing our understanding of innate immune responses, disease correlations, and the advancement of personalized medicine. However, due to the high variability of the KIR region and high level of sequence similarity among different KIR genes, the generic genotyping workflows are unable to accurately infer copy numbers and complete genotypes of individual KIR genes from next-generation sequencing data. Thus, specialized genotyping tools are needed to genotype this complex region.

Methods: Here, we introduce Geny, a new computational tool for precise genotyping of KIR genes. Geny utilizes available KIR allele databases and proposes a novel combination of expectation-maximization filtering schemes and integer linear programming-based combinatorial optimization models to resolve ambiguous reads, provide accurate copy number estimation, and estimate the correct allele of each copy of genes within the KIR region.

Results & discussion: We evaluated Geny on a large set of simulated short-read datasets covering the known validated KIR region assemblies and a set of Illumina short-read samples sequenced from 40 validated samples from the Human Pangenome Reference Consortium collection and showed that it outperforms the existing state-of-the-art KIR genotyping tools in terms of accuracy, precision, and recall. We envision Geny becoming a valuable resource for understanding immune system response and consequently advancing the field of patient-centric medicine.

Keywords: KIR; bioinformatics; combinatorial optimization; computational biology; genotyping; software.

MeSH terms

  • Alleles*
  • Computational Biology / methods
  • Genotype*
  • Genotyping Techniques* / methods
  • High-Throughput Nucleotide Sequencing / methods
  • Humans
  • Receptors, KIR* / genetics
  • Software

Substances

  • Receptors, KIR

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. QZ, MG, and IN were supported by National Science and Engineering Council of Canada (NSERC) Discovery Grant (RGPIN-04973), Canada Research Chairs Program, Canada Foundation for Innovation’s John R. Evans Leaders Fund (CFI JELF) and B.C. Knowledge Development Fund (BCKDF). CH was supported by the BioTalent SWPP program. AH, MF, and SCS were supported by funding from the Intramural Research Programs of the National Cancer Institute (NCI). AH is also funded by the NCI-UMD Partnership Program.